NCT06964958 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06964958
Title	LASER - a Phase 2 Trial of 177Lu-PSMA-617 as Systemic Therapy for Renal Cell Carcinoma (LASER)
Acronym	LASER
Recruitment	Not yet recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Dana-Farber Cancer Institute
Indications	renal cell carcinoma clear cell renal cell carcinoma
Therapies	lutetium Lu 177 vipivotide tetraxetan
Age Groups:	senior \| adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Brigham and Women's Hospital		Boston	Massachusetts	02215	United States	Details
Dana-Farber Cancer Institute		Boston	Massachusetts	02215	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06964958Clinical Trial Detail